Vaxcyte Stock News & Updates
[WKN: A2P6R6 | Symbol: PCVX]
Vaxcyte: Phase 3 Success for VAX-31: Protection Against 31 Bacterial Strains Causes Stock to Rise by 50%
Vaxcyte targets prevention markets with protein conjugates. OPUS-1 data confirm the efficacy of VAX-31...
Vaxcyte Inc.: Needham Sees 143% Price Potential and Names the Stock a Top Recommendation
Pioneering Work through Cell-Free Vaccine Synthesis Vaxcyte Inc. (PCVX) positions itself as a driving...
TOP-5 Analyst Price Targets on January 7, 2025
Dürr [DE0005565204] Bernstein maintains "Outperform" and adjusts the price target from 38 to 39...
- ‹
- 1
- ›